Drug intelligence / Profile preview

Double Lutein Blue

Development stage
Unknown
Lead developer
Alfa Instruments
Modality
Small Molecules
Administration
Intraocular
01

Overview

Double Lutein Blue is a sterile, non-toxic intraocular staining solution used as a surgical adjunct in vitreoretinal surgery, specifically for the visualization and peeling of the internal limiting membrane (ILM) and epiretinal membrane (ERM). Developed by Alfa Instruments and distributed globally by Bausch + Lomb, the formulation contains 2% soluble lutein, 0.05% Pure Benzyl-Brilliant Blue (PBB), and 0.15% trypan blue. The inclusion of lutein provides a dual benefit: it acts as a natural blue light filter and an antioxidant, protecting the retina from potential iatrogenic damage caused by the high-intensity light of the endoilluminator during surgery. PBB is a high-purity dye with a specific affinity for the ILM, while trypan blue stains the ERM, enabling surgeons to clearly distinguish and safely remove these delicate tissues. The product is CE-marked and intended to improve surgical precision while minimizing retinal toxicity.

Brand names
Double Lutein BlueBLutein Double Lutein BlueVitreoCare Double Lutein Blue
Other names
DLB

Beyond the preview

Go deeper on Double Lutein Blue.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Double Lutein Blue.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call